Clinical Trial

Serum Bicarbonate Changes During Laparoscopic Bariatric Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Pneumoperitoneum during laparoscopic bariatric surgery induces carbon dioxide absorption and may lead to perioperative alterations in acid-base balance. Serum bicarbonate (HCO₃-) plays a central role in metabolic compensation; however, the clinical relevance of perioperative bicarbonate changes remains insufficiently defined. This prospective observational study aims to evaluate the association between pneumoperitoneum duration and perioperative serum bicarbonate change (ΔHCO₃-), and to investigate whether ΔHCO₃- is associated with early discharge readiness at 48 hours (DR-48) following laparoscopic bariatric surgery. Patients undergoing laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass will be enrolled consecutively. No alteration of routine clinical care will occur.
Trial Details
NCT Number NCT07445230
Lead Sponsor Istinye University
Conditions Acid Base Disorder
Enrollment 85 participants
Start Date 2026-03-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-03